Previous publications have demonstrated that the IL-33/ST2 signaling axis was involved in the occurrence and development of inflammatory and allergic diseases including rheumatoid arthritis, inflammatory bowel disease, SLE, food allergy, and asthma [20, 31–33]. Here, IL33 is linked to systemic lupus erythematosus.